采用高传能线密度(LET)的12C6+离子束和低LET的X射线辐照人正常肝细胞系HL-7702细胞，利用微卫星不稳定性(MSI)检测来分析直接受照射细胞和通过转移培养基方式旁细胞传代八代子细胞以MSI表征的远后效应。实验结果表明，12C6+离子束诱导的远后效应较X射线的低；旁细胞的远后效应较直接受照射细胞的高；辐射引起的MSI与杂合性丢失(LOH)的发生率具有位点特异性。结果提示，重离子放射治疗较X射线放射治疗对正常组织引发的辐射风险要小，可通过对MSI高发位点的筛选来评估放疗后患者长期生存状况和二次癌症发生风险。
Human normal liver cell line HL-7702 cells were irradiated with high linear energy transfer (LET) 12C6+ions and low-LET X-rays, respectively. Delayed effect in terms of microsatellite instability (MSI) in progenies of the directly irradiated cells and bystander cells, obtained in the way of medium transfer at the 8th passage postirradiation, were examined. The delayed effect induced by the high-LET 12C6+ions was different from that induced by the low-LET X-rays, and a higher incidence of MSI was observed in the progenies of the cells after exposure to the X-rays than to the 12C6+ions. We also found that the delayed effect in the progenies of the bystander cells was much more severe than those of directly irradiated cells. Furthermore, the events of MSI and loss of heterozygosity (LOH) induced by the ionizing radiations were not randomly distributed throughout the genome and specific loci existed indeed. These results imply that the radiation risk to normal tissues is lower in heavy ion therapy than in conventional X-ray radiotherapy, and the analysis of microsatellite loci with MSI high frequency occurrence can be applied to access long-term survival condition and second cancer risk for the patients after radiotherapy.
参考文献
| [1] | PRISE K M, O’SULLIVAN J M. Nat Rev Cancer, 2009, 9(5):351. |
| [2] | SUZUKI K, OJIMA M, KODAMA S, et al. Oncogene, 2003, 22(45):6988. |
| [3] | TAO Jiajun, LI Qiang, WU Qingfeng. Nuclear Physics Review, 2009, 26(3):248.(in Chinese)(陶家军,李强,吴庆丰. 原子核物理评论, 2009, 26(3):248.) |
| [4] | LI Qiang. Acta Laser Biology Sinica, 2003, 12(5):386.(in Chinese)(李强. 激光生物学报, 2003, 12(5):386.) |
| [5] | KRAFT G. Prog Part Nucl Phys, 2000, 45:S473. |
| [6] | LI Honggang. Journal of Practical Training of Medicine, 2005, 33(4):199.(in Chinese)(李红钢. 实用医学进修杂志, 2005, 33(4):199.) |
| [7] | HANS Ellegren. Nature Review Genetics, 2004, 5:435. |
| [8] | GREGORY A P. Genome Biology, 2003, 4(2):104. |
| [9] | WOERNER S M, KLOOR M, von KNEBEL D M, et al. Cancer Biomarkers, 2006, 2(1/2):69. |
| [10] | KARRAN P. Cancer Biology, 1996, 7:15. |
| [11] | DONG Reizeng, CAI Hong, MO Shanjing, et al. Journal of Onco-logy, 2005, 11(5):363.(in Chinese)(董锐增,蔡宏,莫善兢,等. 肿瘤学杂志, 2005, 11(5):363.) |
| [12] | DIETMAIER W, WALLINGER S, BOCKER T, et al. Cancer Res, 1997, 57(21):4749. |
| [13] | NAKANISHI M, TANAKA K, TAKAHASHI T, et al. Int J Radiat Biol, 2001, 77:687. |
| [14] | YAMDA S, YANG T C, GEORGE K, et al. Adv Space Res, 1998, 22(12):1709. |
| [15] | de SCHUTTER H, SPAEPEN M, mc BRIDE W H, et al. Eur J Hum Genet, 2007, 15(7):734. |
| [16] | PANG J Z, QIN L X, WANG Q Q, et al. Chinese Journal of Hepa-tolagy, 2007, 15(12):906. |
| [17] | RIOU P, SAFFROY R, COMOY J, et al. Clin Cancer Res, 2002, 8(10):3178. |
| [18] | ZHAO X, LI J, He Y, et al. Cancer Res, 2001, 61(20):7383. |
| [19] | BOLAND C R, THIBODEAU S N, HAMILTON S R, et al. Cancer Res, 1998, 58(22):5248. |
| [20] | MARPLES B, JOINER M C. Radiat Res, 1993, 133(1):41. |
| [21] | ERIKSSON G. Hereditas,1963, 50(2/3):161. |
| [22] | PENG Qian, FENG Mei. Journal of Cancer Control and Treatment, 2009, 22(1):104.(in Chinese)(彭倩,冯梅. 肿瘤预防与治疗, 2009, 22(1):104.) |
| [23] | MA Y, WU L, LIU C, et al. Cancer Res Clin Oncol, 2009, 135(3):431. |
| [24] | RIOU P, SAFFROY R, COMOY J, et al. Clin Cancer Res, 2002, 8(10):3178. |
| [25] | HUANG L, SNYDER A R, MORGAN W F. Oncogene, 2003, 22(37):5848. |
| [26] | RUGO R E, MUTAMBA J T, MOHAN K N, et al. Oncogene, 2011, 30(6):751. |
- 下载量()
- 访问量()
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%